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pathway in both, phagocytic and nonphagocytic cells, [ 2,3 ] and 
interfere with the microtubule function triggering antiprolifera-
tive and pro-apoptotic effects. [ 5,10,11 ] 
 MWCNTs display interesting biomimetic properties with 
microtubules. [ 11-13 ] These cytoskeletal elements are intracel-
lular protein nanotubes that result from the self-association 
of tubulin into 4 nm polymers, known as protofi laments. [ 14 ] 
Tubulin protofi laments are organized into a circle assembling 
a 25 nm diameter tube, the microtubule (Figure S1, Supporting 
Information). Thus, MWCNTs and microtubules are both 1D 
hollow nanofi laments with a similar length-to-diameter ratio, 
resiliency, self-assembly properties, and a comparable surface 
reactivity [ 12 ] that favors their association into biosynthetic poly-
mers both,  in vitro [ 13 ] and  in vivo . [ 11 ] There is however, a big dif-
ference between these two nanofi laments that has chief biotech-
nological implications. While CNTs are very stable fi laments, 
microtubules are highly dynamic polymers that stochastically 
switch between phases of polymerization–depolymerization on 
the time scale of seconds both,  in vitro and  in vivo. [15] During 
mitosis, the microtubule dynamic behavior increases 20- to 
100-fold to assemble the so-called “mitotic spindle”, a microtu-
bule-based structure responsible for the balanced segregation of 
the chromosomes between the daughter cells. [ 15,16 ] Some of the 
most widely used antineoplastic drugs such as paclitaxel (taxol) 
and their derivatives are microtubule-binding chemicals that 
behave as spindle poisons, inhibiting cell proliferation, leading 
to mitotic arrest and cell death. [ 17–19 ] 
 MWCNTs interact tubulin intracellularly assembling biosyn-
thetic fi laments. [ 11 ] These hybrid microtubules display a sig-
nifi cantly enhanced stability compared to the standard tubulin 
polymers that favors noncentrosomal cytoplasmic microtubule 
nucleation. As the word “centrosome” means, this structure 
is a key organizer of the microtubule cytoskeleton in the cell, 
participating in all cellular activities including cell division and 
migration. CNT-triggered centrosomal abnormalities are well 
documented in the literature. These include aberrant mitotic 
spindle assemblies, chromosomal malsegregation, abnormal 
interphase microtubule arrays, and cytotoxicity in general. [ 5,11,19 ] 
Since centrosomal positioning is a key structure in migrating 
cells, conferring membrane and cytoskeletal directionality, here 
we determine if MWCNTs have the intrinsic ability to hinder 
cancer cell spreading and discuss the molecular mechanics 
behind this effect. 
 For the study we fi rst determined the position and trajec-
tory of the centrosome in migrating HeLa cells treated with 
MWCNTs. As a rule of thumb, migrating cells display a polar-
ized morphology [ 20 ] determined by the so-called, nuclear-centro-
somal axis ( Figure  1 A). This axis, fi rst identifi ed by Van Beneden 
in the 1880s, [ 21 ] contributes to the asymmetric organization of 
 Finding ways to control cancer at the primary site means the 
difference between life and death. Localized tumors can be 
eliminated by surgery and radiation therapy, and as a general 
rule do not represent a life-threatening problem. However, 
when cancer spreads to other tissues it becomes an incurable 
condition where treatments can only delay the progression of 
the disease and prolong survival. 
 Carbon nanotubes (CNTs) represent a highly versatile hetero-
geneous family of nanomaterials that display interesting phys-
ico-chemical properties. [ 1 ] These nanomaterials are well known 
to interact with the biological matter, penetrating inside tissues 
and cells, [ 2,3 ] leading to a plethora of side effects in living organ-
isms. [ 4–7 ] In vitro , CNTs can be actively captured by most cells. [ 2,3 ] 
Once inside the cells, CNTs also intermingle with many subcel-
lular structures at nanoscale, mostly fi laments such as DNA, [ 8 ] 
actin, [ 9,10 ] or microtubules. [ 5,11 ] In particular, multiwalled carbon 
nanotubes (MWCNTs) have been shown to contact cell surface 
receptors, [ 2 ] translocate across cell membranes via the endocytic 
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cell structure during migration, and corresponds to the fi nal 
direction of the displacement. [ 22 ] Microtubules, connected to the 
migrating front of the cell, pull forward the centrosome drag-
ging the nucleus forward, thus redistributing the traction forces 
generated at the cell’s migrating front, to the centrosome, and 
throughout the cytoplasm to produce an effective net cell body 
translation. Accordingly, in cells migrating on 2D substrates, 
the centrosome is typically positioned between the nucleus and 
the leading edge, along this axis. To determine the orientation 
of nuclear-centrosomal axis we performed time-lapse video 
microscopy on live HeLa cells displaying fl uorescently labeled 
centrosomes and nuclei (Experimental section). This allowed 
comparing this axis with the direction of the cell trajectory in 
migrating MWCNT-treated cells and untreated controls. As 
summarized in Figure  1 B, in frozen live-cell images obtained 
from Videos S1–S3 (Supporting Information), the centrosomes 
in MWCNT-treated cells displayed a random perinuclear loca-
tion and were aberrantly positioned with respect to the nuclear 
trajectory. As a result, in MWCNT-treated cells the direction of 
the cell migration (white arrows) and the nuclear–centrosomal 
axes (yellow arrows) were not parallel. Conversely, in untreated-
control HeLa cells centrosomes were located along the nuclear–
centrosomal axis, between the nucleus and the leading edge of 
the cells, just as described by Van Beneden. [ 21 ] 
 To investigate the consequences of these fi ndings, we cal-
culated the average migration speed of control and MWCNT-
treated cells using cell tracking analysis (Experimental Sec-
tion). For the study we investigated various cancer cell lines 
including: (i) HeLa cells; (ii) MCF7 cells, a human breast 
cancer cell line; (iii) SH-SY5Y cells, a neuroblastoma cell line 
originally established from a metastatic tumor; and (iv) U87MG 
cells, a grade IV human glioma cell line. Cells were incubated 
with 25 µg mL −1 MWCNTs for 70 h and were time-lapse video 
recorded for 5 h. This MWCNT concentration produced no 
obvious signs of toxicity but revealed a reduction of more than 
40% in the average speed of HeLa cells treated with MWCNTs. 
A statistically signifi cant cell speed reduction was also shown 
for the other two fast-migrating cancer cell lines, SH-SY5Y and 
U87MG when exposed to MWCNTs ( Table  1 , and Figure  1 C,D). 
A possible interference with MWCNTs settled on the growing 
matrix was also considered. However, under our functionaliza-
tion conditions MWCNTs precipitation or aggregation on the 
growing matrix is never observed. Besides, recent studies have 
shown that CNTs facilitate cell migration. [ 23 ] 
 To further demonstrate our hypothesis we decided to repli-
cate this experiment on real tumor cells isolated from surgical 
specimens. Characteristically, tumor explant derived cancer 
cells are much more heterogeneous than most cancer cell line 
models. We chose glioblastoma multiforme cells (GBM) for the 
study because these cells typically infi ltrate the surrounding 
brain tissue leading to tumor recurrence after surgery. Glio-
blastomas are the most common and aggressive primary brain 
tumor in adults, and have an unfavorable prognosis with a 
median survival time of less than 15 months, mostly due to 
recurrence. For the study we isolated GBM cells from surgical 
specimens that were fully characterized [ 24 ] before exposure 
to 25 µg mL −1 MWCNTs for 70 h. This experiment served to 
confi rm that MWCNTs also triggered a signifi cant antimigra-
tory effect (18% speed reduction) in real tumor-derived cells 
( Figure  2 A, Table  1 ). 
 The presence of intracellular MWCNTs in GBM cells was 
confi rmed using confocal Raman spectroscopy focusing the 
laser within the cell’s cytoplasm. We observed differences in 
the peak positions in the spectrum of intracellular MWCNTs, 
slightly shifted to higher wavenumbers (Figure  2 B, inset), 
together with a decrease in Raman intensities of the D, G, and G′ 
DOI: 10.1002/adhm.201500252
 Figure 1.  MWCNTs produce centrosomal mispositioning and disrupt the nuclear–centrosomal axis hindering cell migration. A) Diagram of the disposi-
tion of the nucleus (N), centrosome (C, green), and microtubule array (red fi laments) in control and MWCNT-treated (MWCNTs in black) migrating 
cells. Microtubule traction forces are also represented (small white and black arrows). The cell polarity and migratory direction (white arrow) relative to 
the nuclear–centrosomal axis (yellow arrow) is indicated. B) Frozen live-cell images obtained from time-lapse videos S1–S3 (Supporting Information) 
of migrating HeLa cells displaying labeled nuclei (blue) and centrosomes (green). The centrosomal trajectories (red arrows), average cell trajectories 
(white arrows), and nuclear–centrosomal axes (yellow arrows) are shown for MWCNT-treated cells and untreated controls. C,D) Representative glio-
blastoma (U87MG) and neuroblastoma (SH-SY5Y) 5 h cell tracking trajectories, respectively. Cultures grown in the absence (control) or presence of 
MWCNTs were recorded during 70 h. Individual cell trajectories indicated by colored lines, are shorter in cells incubated with MWCNTs.
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modes (Figure  2 B and Table S1, Supporting Information). 
As it has been previously shown, CNTs exhibit variations in 
the relative Raman intensities and/or positions for various 
Raman modes depending on different physical [ 25 ] or chem-
ical [ 26,27 ] environments and according to their agglomeration 
state. In this study, functionalized intracellular MWCNTs 
display a well-pronounced G mode indicative of a signifi cant 
dispersion. The overall data also indicated that the coating 
of MWCNTs did not signifi cantly affect the G mode profi le, 
as previously reported for noncovalently modifi ed SWCNTs 
dispersed in aqueous solutions containing peptides [ 25–31 ] or 
proteins. [ 32,33 ] The precise cytoplasmic distribution of the 
intracellular MWCNTs was also determined on a single con-
focal Z-plane obtained across the GBM cell cytoplasm using 
confocal Raman imaging, following the G band at 1586 cm −1 
(Figure  2 C,D). This technique revealed how intracellular 
MWCNTs were localized in small spots throughout the cyto-
plasm, a distribution coinciding with that previously described 
in MWCNT-treated cell lines. [ 11 ] These experiments dem-
onstrate how MWCNTs can also translocate inside surgical 
specimen–derived cancer cells, and how these nanomaterials 
can also hinder GBM cell spreading. 
 Finally, we also explored if the observed antimigratory 
effect was dose-dependent. For the study we treated all the 
DOI: 10.1002/adhm.201500252
 Table 1.  Migration inhibitory effect of MWCNTs for different cancer cells types. 
Cell type Control speed a) MWCNT speed a) Speed reduction [%] DF b)  t / p c) % Statistical signifi cance 
HeLa 12.7 ± 0.6 7.4 ± 0.4 41 245 7.2/<10 −10 >99.99
MCF7  1.6 ± 0.1 1.5 ± 0.1 6 130 0.4/0.64 NS
SH-SY5Y   8.7 ± 0.7 6.8 ± 0.4 22 114 2.3/0.02 95–98
U87MG   8.5 ± 0.2 6.1 ± 0.2 28 249 7.1/<10 −10 >99.99
GBM   9.2 ± 0.2 7.5 ± 0.1 18.5 408 6.5/<10 −9 >99.99
 a) Average speed is shown in nm s −1 ;  b) DF = degrees of freedom;  c) t / p = Student’s  t -test and  p probability. 
 Figure 2.  MWCNTs translocate into the cytoplasm of surgical specimen–derived cancer cells and interfere with cell spreading. A) Phase contrast 
microscopy images of the primary cultures of GBM cells obtained from surgical specimens. Both control and MWCNT-treated cells display a long 
bipolar morphology and no observable toxicity signs. Colored lines indicate 5 h cell trajectories. B) Comparison between the Raman spectra of pristine 
MWCNTs (black) and intracellular MWCNTs (red trace). These Raman spectra were obtained with a 532 nm line of a linear polarized frequency doubled 
Nd:YAG laser. The inset shows a detail of the typical fi ngerprints expected for MWCNTs spectral region corresponding to the D and G bands in order 
to point out the blue-shift of the Raman peak frequencies associated with the functionalization of the intracellular MWCNTs. Though only minor differ-
ences in the peak positions are observed, the spectrum of MWCNTs treated glioblastoma cell is slightly shifted to higher wavenumbers and a decrease 
in Raman intensities of D and, G and G′ modes are observed (Table S1, Supporting Information). C) Phase contrast image of a GBM cell captured 
through 100× objective of the confocal Raman microscope. (Center) Single confocal Z-plane Raman image of the same cell obtained integrating the 
intensities in the 2800–3000 cm −1 region (C–H stretching), integration time of 0.3 s × 10 accumulations, and a point spacing of 0.36 µm. (Right) Con-
focal Raman image obtained at the same confocal Z-plane to determine the localization of intracellular MWCNTs integrating the Raman intensities of 
the G band (1500–1700 cm −1 region). As shown in the color scale (indicating maximum/minimum CCD counts), bright yellow hues indicate the highest 
signals and gray hues low integrated G band intensities. D) Confocal Raman spectra of the cytoplasm of a MWCNT-treated GBM cell (inset, blue cross) 
and extracellular functionalized MWCNTs (inset, red cross). Integration time of 0.5 s × 10 accumulations and 0.3 s × 10 accumulations, respectively.
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with 0, 25, 50, and 75 µg mL −1 of MWCNTs in the growing 
medium for 70 h. Again, this analysis confi rmed a statisti-
cally signifi cant speed reduction, of up to 62%, with dosages of 
50 µg mL −1 (Table S2, Supporting Information). Larger dosages 
(75 µg mL −1 ) triggered a massive cytotoxic effect, suggesting 
excess MWCNTs probably interfere with some other critical 
cellular processes leading to cell death. 
 The interaction of nanomaterials with proteins or lipids, the 
actual biological building blocks, is still poorly understood as 
reviewed by Tay and colleagues. [ 34 ] These studies demonstrate 
that MWCNTs could play a pivotal role in cancer treatment 
in combination to standard therapies interfering with cancer 
cell migration. Other nanomaterials such as TiO 2 , SiO 2 , and 
hydroxyapatite nanoparticles have also been recently shown 
to interfere with cell migration damaging the microtubule 
network. [ 35 ] Our work demonstrates that MWCNTs could play 
a pivotal role in cancer treatment in combination to standard 
therapies interfering with cancer cell migration. We have pre-
viously documented the molecular interaction of MWCNTs 
with tubulin intracellularly, [ 11 ] and how the biomimetic proper-
ties of MWCNTs obstruct microtubule function during mitosis 
behaving as spindle poisons, same as traditional microtubule-
binding drugs such as taxol. Remarkably, the interaction of 
MWCNTs with the microtubule is not site-specifi c. Instead 
MWCNTs appear to interact along the protofi lament surface, [ 36 ]  
and this fact has two major advantages. First, MWCNTs do not 
require a specifi c binding site in the tubulin molecule subject of 
mutations. And second, the MWCNTs interaction with microtu-
bules permits other microtubule-binding drugs to interact with 
their structural pocket in the tubulin molecule. Here we show 
how, in addition to the antiproliferative effect of MWCNTs, 
these nanomaterials also display important antimigratory 
effects in cancer cells. This new intrinsic feature of MWCNTs 
could signifi cantly boost the mechanism of action of traditional 
microtubule-binding cytotoxic chemotherapies [ 16–18 ] and thus 
might serve to bypass some of the drug-resistance mechanisms 
in cancer cells. [ 37 ] Being metastasis the primary cause of death 
for most cancers, we believe these new properties of MWCNTs 
position these nanomaterials as a new ground-breaking type of 
future synthetic microtubule-stabilizing therapies that could 
play a pivotal role in future cancer treatment. 
 Experimental Section 
 MWCNTs Synthesis and Characterization : CNTs of 3–12 walls, with 
outer diameter ranging from 5 to 15 nm were synthesized following 
the catalytic chemical vapor deposition method using Co and Mo 
particles as catalyst. [ 38 ] An aqueous HCl treatment procedure was 
applied to clean and separate the MWCNTs from contaminants. The 
as-prepared MWCNTs were characterized by various techniques including 
Raman spectroscopy, transmission electron microscopy (TEM), and 
thermogravimetric analyses (TGA) (Figure S2, Supporting Information). 
MWCNTs produce a characteristic Raman spectrum distinguishable of 
SWCNTs spectrum revealing typical MWCNT resonances [ 39,40 ] such as the 
dispersive disorder induced D band at 1330 cm −1 , the tangential G band 
at 1586 cm −1 , and the D′ band at 1614 cm −1 . TEM was performed in a 
JEOL JEM 2100 microscope operating at 120 kV. Samples were prepared 
using ethanol as dispersant and omitting the sample centrifugation steps. 
A drop of this suspension was adsorbed onto a Lacey copper grid. The 
TGA was performed with a Perkin Elmer Pyris 1 system. Measurements 
were conducted by heating 9–12 mg of MWCNTs in dry air from 
35 °C up to 1000 °C at a rate of 2 °C min −1 . TGA results showed a typical 
characteristic CNT curve where the oxidations of hexagonal carbon ring 
appeared at 550 °C. Qualitative information on the purity of CNT could be 
obtained from the TGA based on the extent of nonoxidizable residues at 
high temperature. In our measurements, catalytic metal impurities were 
not observed between 600 and 1000 °C. All these techniques confi rmed 
the absence of undesired impurities in these MWCNTs samples. 
 MWCNTs Dispersion and Functionalization : CNTs were debundled and 
dispersed by repeated cycles of vortex mixing followed by mild sonication 
(3 min, frequency of 20 kHz, 130 W in a SONICS Vibracell VCX130) 
and centrifugation in cell culture medium (Dulbecco’s modifi ed Eagle 
medium (DMEM) from Sigma-Aldrich) containing serum and antibiotics 
as previously described. [ 10,11 ] The stability of the stock suspension was 
checked by centrifugation at 14 000  g after each sonication cycle. Visible 
absorption was used to determine MWCNT concentration in the 400–
600 nm range. Further details of the stability and dispersion of MWCNTs 
in the cell culture medium can be found in previous work. [ 10,11 ] A total 
of 3–5 cycles were suffi cient to obtain a well-dispersed concentrated 
suspension of MWCNTs which was rediluted in culture medium to the 
concentrations indicated in the text. 
 Confocal Raman Spectroscopy Imaging : A confocal Raman microscope 
(Alpha300, WITec) equipped with a piezo scanner and a linear polarized 
frequency doubled Nd:YAG laser (532 nm excitation wavelength) 
focused through an air objective (Nikon, 100×, NA = 0.9) was used. To 
avoid damage and heating, the laser power was controlled below 2 mW. 
The spatial resolution is diffraction limited. In the setup used, features 
at a distance of  r = 0.61 × 532/0.9 = 0.36 µm can be distinguished and 
completely resolved at a distance of 0.72 µm. Mapping was done for the 
stack scan with a step size of 0.36 µm in X/Y and a constant Z (depth) 
in a square of 23 × 25 µm on X/Y. To get a better signal-to-noise ratio, 
every spectrum was acquired with an integration time of 0.3 s, meaning 
75 × 75 = 5625 spectra for one image. Images from this multispectra fi le 
were computed by integrating the appropriate Raman peaks using the 
ScanCtrlSpectroscopyPlus software (WITec, Germany). The images were 
constructed mapping the signals of G mode (1500–1700 cm −1 ) and the 
C–H stretching in the 2800–3000 cm −1 region. [ 39,40 ] 
 Cell Culture, Cell Tracking, and Imaging Techniques : The human cancer 
cell line models used (HeLa, MCF7, SH-SY5Y, and U87MG) have been 
thoroughly characterized in the literature. [ 41-43 ] Primary GBM cell cultures 
have been previously characterized by our group. [ 24 ] Cells were grown 
in Dulbecco’s Modifi ed Eagle Medium containing 10% serum at 37 °C, 
5% CO 2 and were exposed to 25 µg mL −1 MWCNTs concentration in 
the culture medium for 70 h (unless otherwise indicated). Controls and 
MWCNT-treated cells were grown on the same culture plate and were 
imaged simultaneously. Centrosomal trajectories were labeled by gene 
transfer with a vector expressing GFP:EB1 in HeLa cells 24 h before 
exposure to MWCNTs in the medium. This vector was kindly provided by 
Dr. Akhmanova (Utrecht University, The Netherlands). Nuclear DNA was 
labeled with Hoechst dye (bis-benzimide) (Sigma-Aldrich). Cell tracking 
analysis was performed on time-lapse video microscopy movies obtained 
@ 15 min/frame during 5 h on a Nikon Eclipse Ti live-cell station, using 
a 10× Nikon NA 0.45. Quantifi cation analysis was performed with the 
NIS-Elements software. The average cell migration speed was obtained 
for a minimum of hundred cells in at least three sets of experiments 
for each condition. Actual numbers of analyzed cells are designated in 
Table  1 as degrees of freedom (DF). Unpaired two-tailed Student’s  t -test 
was used for the statistical evaluation of differences between control and 
treated cells. Probability ( p ) values are also shown. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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